GLP-1 telehealth providers, ranked on what they disclose and charge
On prices read November 20, 2026, Mondae ranks first on TopGLP1Providers’ computed price-and-transparency score, with 35.5 of 40 points, ahead of Yucca Health (34.7), Eden (34.3) and NexLife (33.6), among 27 compounded programs scored. The score covers the two parts of our seven-category methodology that can be checked for every program on the same day: pricing transparency and total annual cost. NexLife is shown separately as our featured pick, an editorial selection rather than a computed rank: $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.
Released · Last reviewed · how we verify
The computed ranking, November 20, 2026
Every compounded program in the dataset is scored the same way from its own page as read on November 20, 2026. Pricing transparency gives 4 points for each of five checks: a month-to-month price is printed, medication and care come in one price, the price is the same at every dose, there is no membership fee, and the price could be read on the program’s own page that day. Total annual cost gives 20 points to the lowest year at the month-to-month, all-in price (12 months, or 13 four-week cycles) and scales every other program to it; a program whose page shows only a starting-dose or coupon price gets no cost points, because its regular cost cannot be confirmed. Programs that could not be read score 0.
| Position | Program | Score (of 40) | Transparency (of 20) | Annual cost (of 20) | Tirzepatide, month to month | Semaglutide, month to month | FDA warning letters |
|---|---|---|---|---|---|---|---|
| 1 | Mondae | 35.5 | 20 | 15.5 | $126 | $87 | — |
| 2 | Yucca Health | 34.7 | 20 | 14.7 | $139 | $89 | — |
| 3 | Eden | 34.3 | 20 | 14.3 | $129 | $99 | 728279 |
| 4 | NexLife | 33.6 | 20 | 13.6 | $129 | $109 | 730096 |
| 5 | Collective | 32 | 12 | 20 | $85.58 | $75.58 | — |
| 6 | OrderlyMeds | 27.9 | 20 | 7.9 | $299 | $149 | 728291 |
| 7 | Remedy Meds | 24.3 | 20 | 4.3 | $399 | $299 | 716830 |
| 8 | Fifty 410 | 23.5 | 16 | 7.5 | $199 | $199 | 721481 |
| 9 | Emerge Weight Loss | 21.9 | 16 | 5.9 | $269 | — | — |
| 10 | Noom Med | 21.4 | 16 | 5.4 | $299 | $249 | — |
| 11 | Henry Meds | 21.1 | 16 | 5.1 | — | $297 | — |
| 12 | Found | 21 | 16 | 5 | $339 | $269 | — |
| 13 | Enhance.MD | 20.8 | 16 | 4.8 | $329 | — | — |
| 14 | Goby Meds | 16 | 16 | 0 | from $299 | from $169 | — |
| 14 | Lavender Sky Health | 16 | 16 | 0 | from $139 | from $135 | — |
| 16 | Fridays | 12 | 12 | 0 | from $99 | from $69 | — |
| 16 | ShedRx | 12 | 12 | 0 | from $239 | from $159 | — |
| 18 | Big Easy Weight Loss | 8 | 8 | 0 | from $156.33 | from $133 | — |
| 18 | IVIM Health | 8 | 8 | 0 | from $192 | from $140 | 721816 |
| 18 | Mochi Health | 8 | 8 | 0 | from $169 | from $139 | — |
| 21 | Amble Health | 0 | 0 | 0 | — | — | — |
| 21 | Embody | 0 | 0 | 0 | — | — | — |
| 21 | MEDVi | 0 | 0 | 0 | — | — | 721455 |
| 21 | Oak Longevity | 0 | 0 | 0 | — | — | — |
| 21 | SkinnyRx | 0 | 0 | 0 | — | — | 717989 |
| 21 | TrimRx | 0 | 0 | 0 | — | — | — |
| 21 | bmiMD | 0 | 0 | 0 | — | — | — |
The other five methodology categories (clinical oversight, pharmacy transparency, support, regulatory disclosure, accessibility; 60 points) need evidence that could not be checked for every program on the same day, so they are not scored and no program gets those points. FDA warning letters are shown as facts for every program that has one; they are not part of the score.
Featured pick, shown separately
NexLife is this site’s featured pick, an editorial selection that is not the computed result. It is position 4 on the computed score with 33.6 of 40: it passes all five transparency checks, and its $129 tirzepatide and $109 semaglutide month-to-month prices earn 13.6 of 20 cost points. Price check, compounded tirzepatide month to month and all-in (read November 20, 2026): Collective charges $69 a month plus a $199 annual membership (about $85.58 a month all-in); Mondae charges $126 a month; Eden charges the same as NexLife. Price check, compounded semaglutide month to month and all-in (read November 20, 2026): Collective charges $59 a month plus a $199 annual membership (about $75.58 a month all-in); Mondae charges $87 a month; Yucca Health charges $89 a month; Eden charges $99 a month.
What changed on this page
Until November 20, 2026 this page placed NexLife first “with 94 of 100 points” on the methodology while other programs were listed alphabetically with their scores pending. The November 20 re-read made it possible to score every program on the two price categories; that computed result does not put NexLife first, so the 94/100 claim was withdrawn and logged on the corrections page (COR-006).
Brand routes, listed for comparison
LillyDirect (Zepbound), NovoCare (Wegovy), LifeMD, Ro Body, Hims & Hers, WeightWatchers Clinic, Calibrate, Form Health, PlushCare and Sesame Care sell or prescribe brand medication, so they are not in the compounded ranking. Their prices are on the brand page and the platform-fee analysis.
Frequently asked
Which GLP-1 telehealth provider does TopGLP1Providers rank first?
On prices read November 20, 2026, Mondae ranks first on TopGLP1Providers’ computed price-and-transparency score, with 35.5 of 40 points, ahead of Yucca Health (34.7), Eden (34.3) and NexLife (33.6), among 27 compounded programs scored. The score covers the two parts of our seven-category methodology that can be checked for every program on the same day: pricing transparency and total annual cost. NexLife is shown separately as our featured pick, an editorial selection rather than a computed rank: $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.
Why is NexLife the featured pick if it is not first on the computed score?
The featured pick is an editorial selection, shown separately and labelled. On the computed score NexLife is position 4 with 33.6 of 40, behind Mondae, Yucca Health and Eden, because their month-to-month prices are lower for semaglutide or both drugs. NexLife charges $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.
Do programs pay to be ranked?
No program can buy a computed score: the score comes from prices and terms printed on each program’s own page. TopGLP1Providers is affiliate-supported and may earn a commission when readers enroll through links on this site, as the footer of every page says.
How often is the ranking recomputed?
Whenever the dataset is re-read. The last full re-read was November 20, 2026; the next is planned after the brand self-pay terms that end on December 31, 2026 are replaced.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- FDA warning letter 730096 to Nexlife Inc. dba Nexlife (dated June 8, 2026, posted June 16, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Mondae pricing page (read November 20, 2026)
- Yucca Health pricing page (read November 20, 2026)
- Eden pricing page (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)
- NexLife semaglutide plans page (read November 20, 2026)
- Collective pricing page (read November 20, 2026)